(Total Views: 86)
Posted On: 09/16/2025 12:46:12 PM
Post# of 25727

$SSII SS Innovations Announces Successful Completion of World’s First Pediatric Pyeloplasty Telesurgery Utilizing the Company’s SSi Mantra Surgical Robotic System
https://www.globenewswire.com/news-release/20...ystem.html
FORT LAUDERDALE, Fla., Sept. 16, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the world’s first pediatric pyeloplasty telesurgery has been successfully performed utilizing the Company’s SSi Mantra surgical robotic system. Dr. Chandra Mohan Vaddi, Managing Director of Preeti Urology & Kidney Hospitals (“Preeti Hospital”), completed the robotic procedure remotely from SS Innovations’ headquarters in Gurugram, India, nearly 1,000 miles away from a 16-month-old patient located at Preeti Hospital in Hyderabad, India.
Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, commented, “Our SSi Mantra surgical robotic system continues to lead the way in pioneering new telesurgeries across procedure types. We are thankful for the work of the team members at Preeti Hospital and Dr. Chandra Mohan Vaddi, who utilized the SSi Mantra to perform the world’s first pediatric pyeloplasty telesurgery. Compared to traditional methods, robotic surgery affords the potential to be more precise, less invasive with smaller incisions, less painful, and quicker with faster recovery times—all important considerations in both the pediatric space and in general surgery. Moreover, as physicians increasingly utilize the SSi Mantra and its telesurgery capabilities to reach patients in rural and remote areas, we further our mission of democratizing advanced surgical robotic care for patients in need.”
To date, more than 50 telesurgeries have been performed, at distances of up to 4,000 miles, utilizing the SSi Mantra surgical robotic system spanning the following categories:
Pediatric
Cardiac
Urology
Gynecology
Oncology
General Surgery
SS Innovations believes that it is addressing the unmet surgical robotic needs of the large and growing pediatrics market, aligning with the Company’s mission of bringing world-class care to underserved communities. The Company intends to continue to expand SSi Mantra’s capabilities in pediatric robotic surgery through the development of smaller instrumentation.
https://www.globenewswire.com/news-release/20...ystem.html
FORT LAUDERDALE, Fla., Sept. 16, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the world’s first pediatric pyeloplasty telesurgery has been successfully performed utilizing the Company’s SSi Mantra surgical robotic system. Dr. Chandra Mohan Vaddi, Managing Director of Preeti Urology & Kidney Hospitals (“Preeti Hospital”), completed the robotic procedure remotely from SS Innovations’ headquarters in Gurugram, India, nearly 1,000 miles away from a 16-month-old patient located at Preeti Hospital in Hyderabad, India.
Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, commented, “Our SSi Mantra surgical robotic system continues to lead the way in pioneering new telesurgeries across procedure types. We are thankful for the work of the team members at Preeti Hospital and Dr. Chandra Mohan Vaddi, who utilized the SSi Mantra to perform the world’s first pediatric pyeloplasty telesurgery. Compared to traditional methods, robotic surgery affords the potential to be more precise, less invasive with smaller incisions, less painful, and quicker with faster recovery times—all important considerations in both the pediatric space and in general surgery. Moreover, as physicians increasingly utilize the SSi Mantra and its telesurgery capabilities to reach patients in rural and remote areas, we further our mission of democratizing advanced surgical robotic care for patients in need.”
To date, more than 50 telesurgeries have been performed, at distances of up to 4,000 miles, utilizing the SSi Mantra surgical robotic system spanning the following categories:
Pediatric
Cardiac
Urology
Gynecology
Oncology
General Surgery
SS Innovations believes that it is addressing the unmet surgical robotic needs of the large and growing pediatrics market, aligning with the Company’s mission of bringing world-class care to underserved communities. The Company intends to continue to expand SSi Mantra’s capabilities in pediatric robotic surgery through the development of smaller instrumentation.

